市場調査レポート

商品コード

1678709

細胞治療技術の市場規模、シェア、動向分析レポート：製品タイプ別、ワークフロー別、細胞タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

Cell Therapy Technologies Market Size, Share & Trends Analysis Report By Product (Raw Materials, Instruments), By Workflow (Separation, Expansion), By Cell Type (T-cells, Stem Cells), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2025年02月12日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF (Single User License)

USD 5,950 857,157円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,001,217円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,289,337円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

細胞治療技術市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の細胞治療技術市場規模は2030年までに174億6,000万米ドルに達し、2025～2030年のCAGRは17.84％を記録すると予測されています。

同市場は、特にがん、自己免疫疾患、再生医療における先進的治療に対する需要の高まりが原動力となっています。自動化、バイオプロセスの革新、研究開発投資の増加、支援的な規制が成長を後押ししています。企業は効率性、拡大性、製品開発を向上させるため、製造能力やパートナーシップを拡大しており、これが細胞治療技術の需要をさらに高めると予想されます。

COVID-19パンデミックは、研究開発投資、臨床検査、先端治療への需要を増加させ、細胞治療技術市場を加速させました。COVID-19の流行は、再生医療や免疫ベースの治療における自動化、効率的な製造、スケーラブルな生産の必要性を浮き彫りにし、技術革新と産業の成長を促進しました。これらの要因が市場の成長を促し、予測期間中に飛躍的に成長すると予測されています。

CAR-T、TCR-T、幹細胞治療を含む先進的な細胞治療の採用が増加していることから、細胞治療技術の需要がさらに高まると予想されます。遺伝子編集、自動化、バイオプロセスにおける革新は、効率性、拡大性、生産品質を向上させています。より多くの個別化治療や再生治療が承認されるにつれて、特殊な機器、原料、製造ソリューションの必要性は高まり続けると考えられます。このような要因が、予測期間中の市場の成長を促すと予測されます。

細胞治療技術のコストが高いため、今後数年間は市場の成長が鈍化する可能性があります。高価な原料、複雑な製造プロセス、厳しい規制が製造コストを高くしています。また、企業は特殊な設備、熟練労働者、先進的技術を必要とするため、経費がかさみます。保険適用範囲が限定的で、価格設定に課題があるため、採用がさらに制限される可能性があります。より良いプロセス、自動化、生産規模の拡大によるコスト削減が、今後の成長の鍵となると考えられます。

細胞治療技術市場のレポートハイライト

製品別では、消耗品セグメントが2024年に42.70%の最大市場シェアを占めました。これは、細胞の培養、拡大、処理に幅広く使用されているためです。研究、臨床検査、商業生産における試薬、成長因子、培地の継続的な需要が大きな成長を牽引しています。一方、ソフトウェアは予測期間中に最も速いCAGRで成長すると予想されています。
ワークフロー別では、分離セグメントは、治療開発と製造における自動化された効率的な細胞分離技術に対する需要の高まりにより、市場をリードし、最も速いCAGR（2025～2030年）で成長すると予想されます。拡大セグメントは予測期間中に大きく成長する見込みです。
細胞タイプ別では、T細胞セグメントは、遺伝子編集と細胞増殖技術の進歩とともに、がん、自己免疫疾患、感染症に対するCAR-TとTCR-T療法の採用が増加していることから、市場を独占し、最も速いCAGR（2025～2030年）で成長すると予想されます。幹細胞セグメントは予測期間中に大きく成長する見込みです。
最終用途別では、細胞治療研究開発への投資の増加、先端治療への需要の高まり、がん、自己免疫疾患、再生治療に対する商業的製造能力の拡大により、バイオ医薬品・製薬企業セグメントが2024年の市場を独占しました。一方、CMO & CROは予測期間中に最も速いCAGRで成長すると予想されます。

セグメントダッシュボード
世界の細胞治療技術市場の製品変動分析
世界の細胞治療技術市場規模と動向分析、製品別、2018～2030年
原料
- 培地
- 血清
- 細胞培養サプリメント
- 抗体
- 試薬と緩衝液
- その他
機器
- 細胞治療処理システム
- 細胞培養システム
- 細胞選別・分離システム
- その他の機器
- ソフトウェア
- 消耗品と付属品

第5章細胞治療技術市場：ワークフロー別、推定・動向分析

セグメントダッシュボード
世界の細胞治療技術市場のワークフロー変動分析
世界の細胞治療技術市場規模と動向分析、ワークフロー別、2018～2030年
分離
拡大
アフェレーシス
充填-仕上げ
凍結保存
その他

第6章細胞治療技術市場：細胞タイプ別、推定・動向分析

セグメントダッシュボード
世界の細胞治療技術市場の細胞タイプの変動分析
世界の細胞治療技術市場規模と動向分析、細胞タイプ別、2018～2030年
T細胞
幹細胞
その他の細胞

第7章細胞治療技術市場：最終用途別、推定・動向分析

セグメントダッシュボード
世界の細胞治療技術市場の最終用途の変動分析
世界の細胞治療技術市場規模と動向分析、最終用途別、2018～2030年
バイオ医薬品・バイオテクノロジー企業
CMOとCRO
その他

第8章細胞治療技術市場：地域別、推定・動向分析

地域別市場シェア分析、2024年と2030年
地域別市場ダッシュボード
市場規模と予測動向分析、2018～2030年
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ノルウェー
- スウェーデン
- デンマーク
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ブラジル
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

企業/競合の分類
戦略マッピング
企業市況分析、2024年
企業プロファイル/上場企業
- Danaher Corporation
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Lonza Group
- Sartorius AG
- Promega
- BD
- Miltenyi BIoTec
- CellPort Software
- Shimadzu

図表

List of Tables

Table 1 List of abbreviation
Table 2 Global cell therapy technologies market, by region, 2018 - 2030 (USD Million)
Table 3 Global cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 4 Global cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 5 Global cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 6 Global cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 7 North America cell therapy technologies market, by country, 2018 - 2030 (USD Million)
Table 8 North America cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 9 North America cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 10 North America cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 11 North America cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 12 U.S. cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 14 U.S. cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 15 U.S. cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 16 Canada cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 17 Canada cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 18 Canada cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 19 Canada cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 20 Mexico cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 21 Mexico cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 22 Mexico cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 23 Mexico cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 24 Europe cell therapy technologies market, by country, 2018 - 2030 (USD Million)
Table 25 Europe cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 26 Europe cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 27 Europe cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 28 Europe cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 29 Germany cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 30 Germany cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 31 Germany cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 32 Germany cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 33 UK cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 34 UK cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 35 UK cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 36 UK cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 37 France cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 38 France cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 39 France cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 40 France cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 41 Italy cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 42 Italy cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 43 Italy cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 44 Italy cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 45 Spain cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 46 Spain cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 47 Spain cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 48 Spain cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 49 Denmark cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 51 Denmark cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 52 Denmark cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 53 Sweden cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 54 Sweden cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
Table 55 Sweden cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
Table 56 Sweden cell therapy technologies market, by end use, 2018 - 2030 (USD Million
Table 57 Norway cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 58 Norway cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
Table 59 Norway cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
Table 60 Norway cell therapy technologies market, by end use, 2018 - 2030 (USD Million
Table 61 Asia Pacific cell therapy technologies market, by country, 2018 - 2030 (USD Million)
Table 62 Asia Pacific cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 63 Asia Pacific cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
Table 64 Asia Pacific cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
Table 65 Asia Pacific cell therapy technologies market, by end use, 2018 - 2030 (USD Million
Table 66 China cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 67 China cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 68 China cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 69 China cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 70 Japan cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 71 Japan cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 72 Japan cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 73 Japan cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 74 India cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 75 India cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 76 India cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 77 India cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 78 South Korea cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 79 South Korea cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 80 South Korea cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 81 South Korea cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 82 Australia cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 83 Australia cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 84 Australia cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 85 Australia cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 86 Thailand cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 87 Thailand cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 88 Thailand cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 89 Thailand cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 90 Latin America cell therapy technologies market, by country, 2018 - 2030 (USD Million)
Table 91 Latin America cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 92 Latin America cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 93 Latin America cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 94 Latin America cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 95 Brazil cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 96 Brazil cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 97 Brazil cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 98 Brazil cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 99 Argentina cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 100 Argentina cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 101 Argentina cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 102 Argentina cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 103 MEA cell therapy technologies market, by country, 2018 - 2030 (USD Million)
Table 104 MEA cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 105 MEA cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 106 MEA cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 107 MEA cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 108 South Africa cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 109 South Africa cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 110 South Africa cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 111 South Africa cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 116 UAE cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 117 UAE cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 118 UAE cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 119 UAE cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
Table 120 Kuwait cell therapy technologies market, by product, 2018 - 2030 (USD Million)
Table 121 Kuwait cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
Table 122 Kuwait cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
Table 123 Kuwait cell therapy technologies market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Cell therapy technologies market: Market outlook
Fig. 5 Cell therapy technologies market: Segment outlook
Fig. 6 Cell therapy technologies market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Cell therapy technologies market driver impact
Fig. 9 Cell therapy technologies market restraint impact
Fig. 10 Cell therapy technologies market: Product outlook and key takeaways
Fig. 11 Cell therapy technologies market: Product movement analysis
Fig. 12 Raw materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 13 Media market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 14 Sera market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Cell culture supplements market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Reagents & buffers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Cell therapy processing systems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Cell culture systems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Cell sorting & separation systems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Other instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Software market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Consumables & accessories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Cell therapy technologies market: Workflow outlook and key takeaways
Fig. 27 Cell therapy technologies market: Workflow movement analysis
Fig. 28 Separation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Expansion market estimates and forecast, 2018 - 2030 (USD Million
Fig. 30 Apheresis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Fill- finish market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Cryopreservation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Cell therapy technologies market: Cell type outlook and key takeaways
Fig. 35 Cell therapy technologies market: Cell type movement analysis
Fig. 36 T-cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Stem cells market estimates and forecast, 2018 - 2030 (USD Million
Fig. 38 Other cells market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Cell therapy technologies market: End use outlook and key takeaways
Fig. 40 Cell therapy technologies market: End use movement analysis
Fig. 41 Biopharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 CMOs & CROs market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 44 Global cell therapy technologies market: Regional outlook and key takeaways
Fig. 45 Global cell therapy technologies market: Regional movement analysis
Fig. 46 North America cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 U.S. cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Canada cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Mexico cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Europe cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UK cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Germany cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 France cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Italy cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Spain cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Denmark cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Sweden cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Norway cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Asia Pacific cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 China cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Japan cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 India cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Thailand cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 South Korea cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Australia cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Latin America cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Brazil cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Argentina cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Middle East and Africa cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 South Africa cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 UAE cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Kuwait cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)

Product Code: GVR-4-68040-516-0

Cell Therapy Technologies Market Growth & Trends:

The global cell therapy technologies market size is anticipated to reach USD 17.46 billion by 2030, registering a CAGR of 17.84% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising demand for advanced treatments, especially in cancer, autoimmune diseases, and regenerative medicine. Automation, bioprocessing innovations, increasing R&D investments, and supportive regulations fuel growth. Companies are expanding manufacturing capabilities and partnerships to improve efficiency, scalability, and product development, which is further anticipated to fuel the demand for cell therapy technologies.

The COVID-19 pandemic accelerated the cell therapy technologies market by increasing R&D investments, clinical trials, and demand for advanced therapies. It highlighted the need for automation, efficient manufacturing, and scalable production in regenerative medicine and immune-based treatments, driving innovation and industry growth. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.

The growing adoption of advanced cell therapies, including CAR-T, TCR-T, and stem cell treatments, is expected to drive further demand for cell therapy technologies. Innovations in gene editing, automation, and bioprocessing are enhancing efficiency, scalability, and production quality. As more personalized and regenerative treatments gain approval, the need for specialized equipment, raw materials, and manufacturing solutions will continue to rise. These factors are thus projected to impel the market's growth over the forecast period.

The high cost of cell therapy technologies could slow market growth in the coming years. Expensive raw materials, complex manufacturing, and strict regulations make production costly. Companies also need specialized equipment, skilled workers, and advanced technology, adding to expenses. Limited insurance coverage and pricing challenges may further restrict adoption. Reducing costs through better processes, automation, and scaling up production will be key for future growth.

Cell Therapy Technologies Market Report Highlights:

Based on products, the consumables segment held the largest market share of 42.70% in 2024 due to their wide use in cell culture, expansion, and processing. The recurring demand for reagents, growth factors, and media in research, clinical trials, and commercial production has driven significant growth. On the other hand, software is expected to grow at the fastest CAGR over the forecast period
Based on workflow, the separation segment is expected to lead the market and grow at the fastest CAGR (2025-2030) due to increasing demand for automated, efficient cell isolation techniques in therapy development and manufacturing. The expansion segment is expected to grow significantly over the forecast period
Based on cell-type, the T-cells segment is expected to dominate the market and grow at the fastest CAGR (2025-2030) due to increasing adoption of CAR-T and TCR-T therapies for cancer, autoimmune diseases, and infectious diseases, along with advancements in gene editing and cell expansion technologies. The stem cells segment is expected to grow significantly over the forecast period.
Based on end use, the biopharmaceutical & pharmaceutical companies segment dominated the market in 2024 due to increasing investments in cell therapy R&D, growing demand for advanced treatments, and expanding commercial manufacturing capabilities for cancer, autoimmune, and regenerative therapies. On the other hand, CMOs & CROs are expected to grow at the fastest CAGR over the forecast period

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Workflow
- 1.2.3. Cell Type
- 1.2.4. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Cell Therapy Technologies Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Advancements in Cell-Based Therapies
  - 3.2.1.2. Increased Funding and Investment
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High Costs and Manufacturing Challenges
3.3. Cell Therapy Technologies Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Therapy Technologies Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Cell Therapy Technologies Market Product Movement Analysis
4.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Raw Materials
- 4.4.1. Raw materials market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Media
  - 4.4.2.1. Media market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Sera
  - 4.4.3.1. Sera market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Cell Culture Supplements
  - 4.4.4.1. Cell Culture Supplements market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.5. Antibodies
  - 4.4.5.1. Antibodies market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.6. Reagents & Buffers
  - 4.4.6.1. Reagents & buffers market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.7. Others
  - 4.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Instruments
- 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. Cell Therapy Processing Systems
  - 4.5.2.1. Cell therapy processing systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Cell Culture Systems
  - 4.5.3.1. Cell culture systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.4. Cell Sorting & Separation Systems
  - 4.5.4.1. Cell sorting & separation systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.5. Other Instruments
  - 4.5.5.1. Other instruments market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.6. Software
  - 4.5.6.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.7. Consumables & Accessories
  - 4.5.7.1. Consumables & accessories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cell Therapy Technologies Market: Workflow Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Cell Therapy Technologies Market Dosage Workflow Movement Analysis
5.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Separation
- 5.4.1. Separation market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Expansion
- 5.5.1. Expansion market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Apheresis
- 5.6.1. Apheresis market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Fill- Finish
- 5.7.1. Fill- finish market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Cryopreservation
- 5.8.1. Cryopreservation market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
- 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cell Therapy Technologies Market: Cell Type Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Cell Therapy Technologies Market Cell Type Movement Analysis
6.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Cell Type, 2018 to 2030 (USD Million)
6.4. T-cells
- 6.4.1. T-cells market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Stem Cells
- 6.5.1. Stem cells market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Other Cells
- 6.6.1. Other cells market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cell Therapy Technologies Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Cell Therapy Technologies Market End Use Movement Analysis
7.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Biopharmaceutical & Biotechnology Companies
- 7.4.1. Biopharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
7.5. CMOs & CROs
- 7.5.1. CMOs & CROs market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Others
- 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cell Therapy Technologies Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Regulatory framework
  - 8.4.2.3. Competitive scenario
  - 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Regulatory framework
  - 8.4.3.3. Competitive scenario
  - 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Regulatory framework
  - 8.4.4.3. Competitive scenario
  - 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Europe
- 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory framework
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Regulatory framework
  - 8.5.4.3. Competitive scenario
  - 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Regulatory framework
  - 8.5.5.3. Competitive scenario
  - 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Regulatory framework
  - 8.5.6.3. Competitive scenario
  - 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Regulatory framework
  - 8.5.7.3. Competitive scenario
  - 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.8. Sweden
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Regulatory framework
  - 8.5.8.3. Competitive scenario
  - 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.9. Denmark
  - 8.5.9.1. Key country dynamics
  - 8.5.9.2. Regulatory framework
  - 8.5.9.3. Competitive scenario
  - 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Regulatory framework
  - 8.6.3.3. Competitive scenario
  - 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Regulatory framework
  - 8.6.4.3. Competitive scenario
  - 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Australia
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Regulatory framework
  - 8.6.5.3. Competitive scenario
  - 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. South Korea
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Regulatory framework
  - 8.6.6.3. Competitive scenario
  - 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Regulatory framework
  - 8.6.7.3. Competitive scenario
  - 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Regulatory framework
  - 8.7.3.3. Competitive scenario
  - 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.8. MEA
- 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Regulatory framework
  - 8.8.2.3. Competitive scenario
  - 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Regulatory framework
  - 8.8.3.3. Competitive scenario
  - 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Regulatory framework
  - 8.8.4.3. Competitive scenario
  - 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key country dynamics
  - 8.8.5.2. Regulatory framework
  - 8.8.5.3. Competitive scenario
  - 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
- 9.4.1. Danaher Corporation
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Merck KGaA
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Thermo Fisher Scientific Inc.
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Lonza Group
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Sartorius AG
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. Promega
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. BD
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Miltenyi Biotec
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. CellPort Software
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. Shimadzu
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product benchmarking
  - 9.4.10.4. Strategic initiatives

細胞治療技術の市場規模、シェア、動向分析レポート：製品タイプ別、ワークフロー別、細胞タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

Cell Therapy Technologies Market Size, Share & Trends Analysis Report By Product (Raw Materials, Instruments), By Workflow (Separation, Expansion), By Cell Type (T-cells, Stem Cells), By End Use, By Region, And Segment Forecasts, 2025 - 2030

細胞治療技術市場の成長と動向

細胞治療技術市場のレポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章細胞治療技術市場の変数、動向、範囲

第4章細胞治療技術市場：製品別、推定・動向分析

第5章細胞治療技術市場：ワークフロー別、推定・動向分析

第6章細胞治療技術市場：細胞タイプ別、推定・動向分析

第7章細胞治療技術市場：最終用途別、推定・動向分析

第8章細胞治療技術市場：地域別、推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Cell Therapy Technologies Market Growth & Trends:

Cell Therapy Technologies Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Cell Therapy Technologies Market Variables, Trends & Scope

Chapter 4. Cell Therapy Technologies Market: Product Estimates & Trend Analysis

Chapter 5. Cell Therapy Technologies Market: Workflow Estimates & Trend Analysis

Chapter 6. Cell Therapy Technologies Market: Cell Type Estimates & Trend Analysis

Chapter 7. Cell Therapy Technologies Market: End Use Estimates & Trend Analysis

Chapter 8. Cell Therapy Technologies Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

細胞治療技術の市場規模、シェア、動向分析レポート：製品タイプ別、ワークフロー別、細胞タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

Cell Therapy Technologies Market Size, Share & Trends Analysis Report By Product (Raw Materials, Instruments), By Workflow (Separation, Expansion), By Cell Type (T-cells, Stem Cells), By End Use, By Region, And Segment Forecasts, 2025 - 2030

細胞治療技術市場の成長と動向

細胞治療技術市場のレポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 細胞治療技術市場の変数、動向、範囲

第4章 細胞治療技術市場：製品別、推定・動向分析

第5章 細胞治療技術市場：ワークフロー別、推定・動向分析

第6章 細胞治療技術市場：細胞タイプ別、推定・動向分析

第7章 細胞治療技術市場：最終用途別、推定・動向分析

第8章 細胞治療技術市場：地域別、推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Cell Therapy Technologies Market Growth & Trends:

Cell Therapy Technologies Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Cell Therapy Technologies Market Variables, Trends & Scope

Chapter 4. Cell Therapy Technologies Market: Product Estimates & Trend Analysis

Chapter 5. Cell Therapy Technologies Market: Workflow Estimates & Trend Analysis

Chapter 6. Cell Therapy Technologies Market: Cell Type Estimates & Trend Analysis

Chapter 7. Cell Therapy Technologies Market: End Use Estimates & Trend Analysis

Chapter 8. Cell Therapy Technologies Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章細胞治療技術市場の変数、動向、範囲

第4章細胞治療技術市場：製品別、推定・動向分析

第5章細胞治療技術市場：ワークフロー別、推定・動向分析

第6章細胞治療技術市場：細胞タイプ別、推定・動向分析

第7章細胞治療技術市場：最終用途別、推定・動向分析

第8章細胞治療技術市場：地域別、推定・動向分析

第9章競合情勢